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LENGTH OF ILLNESS DOES NOT PREDICT COGNITIVE DYSFUNCTION IN 
CHRONIC FATIGUE SYNDROME 
 
 
Abstract 
Neuropsychological studies have shown cognitive impairment in Chronic Fatigue Syndrome 
(CFS), particularly in information processing speed. The aim of this study was to examine the 
evolution of cognitive impairment in CFS. The evolution is one the most disabling aspects of 
the CFS, and it has received little attention in literature. Fifty-six women with CFS were 
assessed with neuropsychological tests. Patients were divided into 3 groups based on the 
duration of the disease. There were no differences between groups in terms of cognitive 
function. The cognitive impairment in CFS was not found to be more severe with longer 
disease duration. These data suggest that there is no progressive cognitive impairment in 
patients with CFS. Therefore, the cognitive deficits in CFS should be treated with cognitive 
rehabilitation programs focused on improving emotional distress associated to the illness and 
promoting functional abilities. 
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Introduction 
Fatigue is a common complaint in the general population, but when it occurs in the 
clinical entity known as chronic fatigue syndrome (CFS), it can produce distress and 
suffering, and have negative repercussions on the patient’s quality of life. CFS is 
characterized by prolonged, unexplained fatigue for at least 6 months, experienced as severe 
mental and physical exhaustion. Case definition is used to aid diagnosis, being the most 
frequent the US Centers for Disease Control and Prevention (CDC, Fukuda, et al., 1994) and 
the Oxford (Sharpe, et al., 1991) criteria. They define CFS on the basis of the concurrent 
presence of at least 4 of the following criteria: self-reported memory alteration, painful 
swallowing, tender cervical or axillary lymph nodes, myalgia, recent onset of headaches or 
headaches of a new type, pain in several joints without signs of inflammation, unrefreshing 
sleep, and maliase following exertion and lasting more than 24 hours. For this study we have 
focused in cognitive impairments and their evolution using a neuropsychological examination 
to asses the cognitive impairments.   
Cognitive impairment is one of the most common symptoms in CFS. Figures from 
general population studies show prevalences of CFS ranging from 0.007% to 2.8% and the 
89% of these people experiencing memory and concentration problems  (Jason, et al., 1999). 
Many people with CFS describe their cognitive difficulties as one of the more disabling and 
troubling symptoms of their illness (Abbey & Garfinkel, 1991). The cognitive complaints 
frequently reported by these patients are difficulties with concentration, decreased memory 
for recent events, poor word-finding ability, and slowing of information processing 
(Grafman, et al., 1993). These deficits are included in the diagnostic criteria of the syndrome, 
however, CFS patients´ cognitive functioning performance, including memory, attention, and 
concentration tests; does not reflect their high level of cognitive complaints. 
Page 3 of 18 
Studies assessing the cognitive performance of CFS patients with standardized 
neuropsychological tests have obtained inconsistent results. The most constant findings 
include slowed information processing speed, impaired working memory, and slowed 
reaction time (Busichio, Tiersky, Deluca, & Natelson, 2004; Cockshell & Mathias, 2010; 
Michiels & Cluydts, 2001). The origins of the cognitive dysfunction associated with CFS 
remain unknown, although increasingly more studies are attempting to objectively determine 
and answer this question.  
Some authors have described anatomical alterations in these patients (Lange, et al., 
1999), In a recent study, a reduction in prefrontal cortical volume was found in patients with 
CFS relative to a healthy control group (de Lange, et al., 2008). In addition, neuroendocrine 
studies have provided evidence suggesting functional dysfunctions in the hypothalamic-
pituitary-adrenal axis. A reduction in cortisol levels and increased serotonergic 
neurotransmission has been observed in patients with CFS (Cleare, et al., 1995), and this 
could also be related to alterations in the cognitive capacity. Some research has included as 
control group patients with multiple sclerosis, a neurological disease whose cognitive 
impairments are similar to the patient with CFS and worse as the disease progresses (Daly, 
Komaroff, Bloomingdale, Wilson, & Albert, 2001).  
Another hypothesis is that depression and anxiety could be associated with cognitive 
deficits. However, the data about the role of these factors in cognitive functioning in CFS are 
not consistent. Some authors have found a relationship between symptoms of depression and 
anxiety and cognitive deficits in a variety of cognitive measures (Michiels, Cluydts, & 
Fischler, 1998; L. A. Tiersky, Matheis, Deluca, Lange, & Natelson, 2003) whereas others 
report that the deficit is not secondary to the emotional status (Busichio, et al., 2004; 
Dickson, Toft, & O'Carroll, 2009; Short, McCabe, & Tooley, 2002). Nowadays, the evidence 
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suggests that impaired cognition in chronic fatigue syndrome cannot be explained solely by 
the presence of a psychiatric condition. 
Most patients report a progressive worsening in cognitive symptoms with longer 
disease duration. Currently there are few studies that focus on this hypothesis. There is one 
study that examined long-term change in neuropsychological functioning in individuals with 
CFS over a range 24-63 months. This study showed no changes in attention (forward and 
backward digits) and memory functions (California Verbal Learning Test, Rey–Osterreith 
Complex Figure Test) over the time (Lana A. Tiersky, et al., 2001). Other studies associated 
changes in cognitive function with improvement in patients with CFS. Cope et al, studied 14 
patients with CFS over the course of an average of 4,4 months, showing that patients 
significantly improved on a block design task, a learning task, and a verbal paired associates 
task (Cope, Pernet, Kendall, & David, 1995). Vercoulen et al. (1996) found subjective 
concentration difficulties significantly decreased over time in patients with CFS when they 
improve (Vercoulen, et al., 1996). However, there are some limitations in these studies: the 
small sample size, the short duration of follow-up, the reduced neuropsychological batteries. 
In addition, the studies about the course of CFS showed that the symptoms persist in more 
than half of patients (Cairns & Hotopf, 2005).  
The purpose of the study is to assess the cognitive impairment throughout the disease 
course. Based on studies documenting the worsening in the evolution of the disease (Cairns 
& Hotopf, 2005) and on our clinical data, we hypothesized that patients with CFS would 
show an increase in cognitive impairment with progression of the disease.  
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Material and methods 
 
Patients 
The study sample included 56 patients diagnosed with CFS according to the criteria of 
Fukuda by an internal doctor from the Chronic Fatigue Unit of Vall d’Hebron University 
Hospital in Barcelona (Spain). Patients were recruited between October 2008 and October 
2009. The criteria for inclusion were a diagnosis of CFS and age between 18 and 65 years. 
Patients were excluded if they had a severe mental disorder (eg, bipolar disorder, psychotic 
disorder, borderline personality), were drug abusers, or if they were currently affected by, or 
had a history of, neurological disorders or other organic diseases that involve cognitive 
alterations. The sociodemographic and clinical characteristics of the patients are summarized 
in Table 1.  
 
Table 1. Sociodemographic and clinical characteristics of the sample 
Variables  N=56 
Age, years a 46.75 (7.67)  
Caucasianb 56 (100) 
Education levelb 
               Attended elementary school 
  Elementary school graduate 
  Secondary education 
  College education 
 
14 (25.1) 
13 (23.2) 
18 (32.1) 
11 (19.6) 
Currently working b 20 (35.7) 
Diagnosis CFS (months)a 46.84 (39.07) 
Age at onset of CFSa 36.65 (10.85) 
              aMean (SD), bFrequency (percentages) 
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Assessment 
The sociodemographic and disease data, were collected from the information provided 
by the patients. The presence of psychopathology was assessed by a clinical interview 
following Diagnostic Statistical Manual of Mental Disorders, Fourth Edition, Text Revision 
criteria (American Psychiatric Association, 2001). The degree of fatigue was evaluated with 
the Fatigue Impact Scale, (FIS, Fisk, et al., 1994). The Hospital Anxiety and Depression 
Scale (HADS Zigmond & Snaith, 1983)  was also administered. 
The neuropsychological assessment consisted of administration of an extensive 
battery of neuropsychological tests previously translated and transculturally adapted. This 
battery was validated in an own sample of 250 healthy subjects, confirming no significant 
differences with the original parameters. 
The battery was designed to comprehensively assess five cognitive domains: attention 
and concentration, reaction time, memory, motor functioning and executive functioning. 
Attention and concentration: Digit Span WAIS-III (Wechsler, 1999), Mental Control (WMS-
III) (Wechsler, 2004), Symbol Digit Modalities Test (SDMT) (Smith, 1982), Paced Auditory 
Serial Addition Test (PASAT) (Gronwall, 1977); reaction time: California Computerized 
Assessment Package (CalCAP) (Miller, 1990); memory: Rey Auditory Verbal Learning Test 
(AVLT) (A. Rey, 1964) and Rey-Osterreith Complex Figure (ROCF, immediate and delayed 
recall) (A.  Rey, 1987); Psychomotor speed: Grooved pegboard (Klove, 1963); and executive 
functioning: Stroop Test (Golden, 1994) Trail-Making Test (TMT) (Reitan & Wofson, 1985), 
verbal fluency test (FAS) (Benton & Hamsher, 1978), and Tower of London Test (Shallice, 
1982).  Premorbid intellectual capacity was assessed by the vocabulary subtest of the WAIS-
III (Wechsler, 1999). The great majority of these tests were frequently used to assess 
cognitive performance in CFS (Cockshell & Mathias, 2010). In addition, we included mental 
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control to assess concentration, a deficit frequently referred by patients with CFS. All the 
tests were administered according to standardized procedures published in each test’s manual.  
Procedure 
The patients comprising our sample were consulting at the Chronic Fatigue Unit of 
our hospital. Based on their arrival at the Unit and following the inclusion criteria, they were 
referred to the Psychiatry Department to undergo a psychological examination. The 
assessment was carried out in 2 sessions. In the first, a clinical psychologist interviewed the 
patient, recorded sociodemographic and clinical data, and conducted a psychopathological 
examination. In the second session, which took place within 2 weeks, neuropsychological 
assessment was performed by a neuropsychologist. All sessions were performed under the 
same conditions and each one lasted no more than 2 hours.   
All the participants received information before the evaluations were carried out, 
including aim of the study, the benefits we were attempting to achieve, and the procedure to 
follow, with emphasis on the voluntary nature of their role. After receiving this information, 
patients signed an informed consent form to participate. This study was approved by the by 
the ethics committee of the Vall d'Hebron University Hospital. 
Design 
A cross-sectional study design was used, consisting of evaluation of the cognitive 
status of CFS patients at a specific time point during the course of the condition. The 
variables examined included sociodemographic data (age, sex, educational level, and work 
status), clinical variables related to the disease (time since the diagnosis, time since the onset 
of symptoms, and degree of fatigue), the presence of depression (assessed by clinical 
interview and the HADS), and variables referring to the data obtained in the 
neuropsychological tests.  
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Patients were divided into 3 groups based on the time since the disease was diagnosed: 
less than 12 months, from 12 to 48 months, and more than 48 months.  
Statistical analysis 
To achieve the proposed objectives of the study, data analyses were performed with 
SPSS for Windows (version 15.0; SPSS Inc., Chicago). A descriptive univariate analysis was 
carried out in order to describe the sample. The raw scores on the tests were adjusted 
according to normative data and transformed to T scores (mean=50, dt=10), correcting for the 
effect of age and education level on neuropsychologic performance. This allowed us to obtain 
a score, and tests with a T score of less than 40 were considered to indicate impairment, as 
considered by Busichio et al. (2004). As a result, a profile of cognitive impairment consisting 
of percentages of impairment in each group was obtained. The distribution of 
sociodemographic and clinical variables in the 3 groups of patients with differing disease 
duration was analyzed with one-factor ANOVA or chi-square tests, depending on the type of 
variable. The percentage of cognitive impairment over the three groups was compared using 
chi-square tests. 
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Results 
 The distribution of the sociodemographic and clinical variables in the 3 groups (Table 
2) was homogeneous. 
 
Table 2. Comparison of sociodemographic and clinical variables in the 3 CFS groups, 
divided according to disease duration   
 
Variables CFS <12 months 
(n=15) 
CFS 12-48 
months 
(n=21) 
CFS >48 months 
(n=20) 
P 
Agea 47.20(4.71) 47.24 (8.20) 45.95 (8.88) .828c 
Years of educationa 11.33 (3.70) 10.24 (3.62) 12.05 (4.23) .269c 
Currently working b 8 (53.3) 8 (38.1) 4 (20.0) .084 d 
HADSa 21.93 (7.69) 23.05 (7.74) 24.84 (8.88) .574c 
Age at onset of CFSa 41.67 (6.95) 35.52 (11.58) 34.10 (11.39) .098c 
FISa 129.79 (30.07) 134.26 (21.27) 139 (17.25) .540 c 
Premorbid intelligence 
levela 
55.36 (7.53) 
 
 
57.00 (8.75) 56.85 (8.12) .826c 
 
aMean (SD), bFrequency (percentages),  cANOVA, dchi-square test 
HADS indicates Hospital Anxiety and Depression Scale; FIS, Fatigue Impact Scale 
 
More than half of the patients showed a score above 40 (impairment) in processing 
speed (specifically in the CalCAP, TMT, and Stroop tests) and psychomotor functioning 
(Grooved pegboard test). Results for the remaining tests were within normal limits. 
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<   12 months,          12-48 months,         >48 months. AVL indicates Rey Auditory Verbal Learning test;  ROCF, Rey –Osterrieth Complex 
Figure; RT, reaction time; TMT, Trail Making Test; TOL, Tower of London 
 
The cognitive profile of the sample of CFS patients is shown in Figure 1. Comparison of the 
neurophysiologic profile between the 3 CFS groups showed no statistically significant 
differences. 
 
 
 
 
 
Figure 1. Percentage of impaired patients (T scores above 40) by 
neuropsychological tests according to disease duration 
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Discussion 
To our knowledge the present study is one of the first to examine the evolution of 
cognitive impairment along the illness in CFS, using groups of patients with different 
duration of illness. We opted to research this topic because there is a relative lack of previous 
research despite that many patients consider these cognitive symptoms to be the main source 
of their disability (Moss-Morris, Petrie, Large, & Kydd, 1996).  
Consistent with previous studies, impairment scores were found in test that measure 
information processing speed, assessed with the CalCAP, TMT, and Stroop Test, Grooved 
pegboard (Cockshell & Mathias, 2010; Michiels & Cluydts, 2001). The punctuations of these 
tests in our study is located at one standard deviation below normal, suggesting the presence 
of mild cognitive impairment (Busichio, et al., 2004). So it is important to follow-up these 
patients to see their evolution. The study of the evolution of cognitive functioning, it is also 
necessary to know the impact of the disease on cognition, similar to other diseases that 
present neuropsychological disorders such as multiple sclerosis. Hence, this group of patients 
was compared to CFS patients (Daly, et al., 2001). 
We hypothesized that patients with CFS would show an increase in cognitive 
impairment with progression of the disease. Nonetheless, the data did not support this 
hypothesis, as there were no significant differences in the neuropsychological tests scores 
between the 3 groups of patients with different disease durations.  
These data point out that the cognitive impairment in CFS patients does not worsen 
over the course of the condition. It must be noted, other variables that can have an influence 
on cognitive performance, such as age and the educational level, were distributed 
homogeneously among the 3 groups. The same was true regarding the prevalence of 
depression, another factor known to affect cognitive function.    
Page 12 of 18 
These data contradicts the longitudinal studies that show improvement in some 
cognitive functions (Cope, et al., 1995; Lana A. Tiersky, et al., 2001; Vercoulen, et al., 1996). 
However, these studies have some limitations. Cope et al., used a very small sample with 14 
patients and a short test-retest interval of 4.4 months, so the improvement showed in the 
neuropsychological tests could be the result of practice effect. The practice effect is 
associated to repeated examinations of the same neuropsychological assessment, this have 
been studied in healthy subjects and patients with different illness (Lezak, 1995). In the 
present study, there is not any practice effect, because it is a cross-sectional study, with only 
one examination. 
Tiersky et al. (2001), included measures of attention (PASAT, forward and backward 
digit) and memory (CVLT and ROCFT), but this study didn´t incorporate other cognitive 
tests in which patients’ performance is impaired such as Stroop reaction time, AVLT and 
motor Functioning (Cockshell & Mathias, 2010). So, to study how the length of the illness 
affects  cognitive impairment in CFS patients, we should include a neuropsychological 
battery with measures that have been shown to be altered in these patients. Finally, Vercoulen 
et al. (1996), used subjective measures of concentration, so these data are less objective than 
neuropsychological tests. 
The possible progression of the disease to irreversible cognitive impairment, is one of 
the main concerns in patients with CFS. This data suggests that cognitive impairment does 
not worsen along the course of CFS. However, patients with CFS present cognitive deficits 
that should be treated. An alternative could be through the incorporation of cognitive 
rehabilitation programs in the management of these patients. There are some studies that 
found an association of neuropsychological deficits with functional impairment in patients 
with chronic fatigue syndrome, similar to other illnesses than HIV, multiple sclerosis, 
Alzheimer’s disease, and stroke (Christodoulou, et al., 1998). Cognitive impairment has 
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functional implications in patients’ lives, so the intervention programs could focus on 
developing compensational strategies and promoting active use of preserved functions, as 
well as providing psychoeducation about the impairment and emotional interventions for 
cases that might require this treatment. In this line, cognitive behavioral therapy has been 
shown to improve the health of SFC patients (Prins, van der Meer, & Bleijenberg, 2006; 
Siessmeier, et al., 2003), also increasing the volume of prefrontal cortex (de Lange, et al., 
2008). This brain area is involved in cognitive functions altered in patients with CFS. Based 
on these results, future studies should broaden the knowledge of the effect of psychological 
treatment on cognitive deficits in CFS.  
The main limitation of this study is the absence of longitudinal data to follow-up the 
sample at different time points. Nevertheless the use of cross-sectional designs reduces the 
practice effects on performance in neuropsychological tests. Although this study didn´t 
include a healthy control group , all the normative data used was extracted from the same 
local sample. Future studies in this line could include a group without CFS, determine the 
baseline cognitive performance in both groups, and then perform additional assessments over 
time. In addition, no objective validation of the performance of the subjects was included 
although it was clinically assessed. Further studies could include objective effort measures 
like the Test of memory malingering (TOMM, Tombaugh, 1996; cited in Busichio, et al., 
2004). Finally, it must be noted that in order to homogenize the sample of patients and taking 
into account the influence of gender on cognitive function (Lezak, 1995) men were excluded 
from this study. Considering that the prevalence of CFS in women is higher than men (Jason, 
et al., 1999), men representativeness would require a much more larger sample of patients. 
Although in our study the language and ethnic characteristics of the sample was very 
homogeneous, it should also be taken into account in future studies.  
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In conclusion, the cognitive impairment occurring on CFS patients was not found to 
be more severe with longer disease duration. This fact would support the implementation of 
rehabilitation programs to optimize the patients’ cognitive resources, improve their quality of 
life, and increase their self-confidence.  
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